Pharmacists in Vestavia, AL Accepting Medicare
49 Pharmacists found. Showing 41 - 49
 Cameron A Wlaschin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3150 Green Valley Rd, Vestavia, AL 35243 Phone: 205-967-7483 |
 Dr. Stephanie Elizabeth Cocherell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Centerview Dr, Vestavia, AL 35216 Phone: 205-824-3652 |
Melissa Ann Dixon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 784 Montgomery Hwy, Vestavia, AL 35216 Phone: 205-824-6010 |
Mrs. Aileen Giddens, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3965 Crosshaven Dr, Vestavia, AL 35243 Phone: 205-969-0767 |
Dr. Natalie Rudyshyn, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3023 Massey Rd, Unit K, Vestavia, AL 35216 Phone: 334-791-1155 |
Christopher Hamilton Vought, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3201 Endeavor Ln, Vestavia, AL 35242 Phone: 205-967-5998 |
Dr. Patrick Cashman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 784 Montgomery Hwy, Vestavia, AL 35216 Phone: 205-824-6010 |
Lisa Moore Looney, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 Montgomery Hwy, Vestavia, AL 35216 Phone: 205-822-6022 Fax: 205-822-3640 |
Mr. Gary Keith Emerine, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3925 Crosshaven Dr, Vestavia, AL 35243 Phone: 205-969-1260 Fax: 205-969-2679 |
News Archive
Results of IES presented at ECCO
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
Study points to potential way to make people behave in less selfish, more altruistic ways
It's an age-old quandary: Are we born "noble savages" whose best intentions are corrupted by civilization, as the 18th century Swiss philosopher Jean-Jacques Rousseau contended? Or are we fundamentally selfish brutes who need civilization to rein in our base impulses, as the 17th century English philosopher Thomas Hobbes argued? After exploring the areas of the brain that fuel our empathetic impulses - and temporarily disabling other regions that oppose those impulses - two UCLA neuroscientists are coming down on the optimistic side of human nature.
NCHC Action Fund calls for redoubling efforts to enact comprehensive health system reform
The effort to fix our dysfunctional, inequitable and unsustainable health system is at a crucial juncture. Without prompt and decisive leadership, defeat, as it has for over a century, will again prevail over reform.
FTC approval of Express Scripts-Medco merger triggers new battlegrounds
Drug Stores and community pharmacists have pledged to fight on in the courts, but some consumer advocates see a silver lining in the merger.
Lorus Therapeutics allowed Canadian patent to protect anticancer drugs
Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc., has been allowed a patent by the Canadian Patent Office entitled "Antitumor Antisense Sequences Directed Against R1 and R2 Components of Ribonucleotide Reductase."
› Verified 1 days ago
Pharmacists
Counselors
Occupational Therapists
Dentists
Psychologists
Clinical Social Workers